ArticleJournal of oncology practice2015
Patients and Physicians Can Discuss Costs of Cancer Treatment in the Clinic.
Article in Journal of oncology practice, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03780491 (Understanding and Addressing Patient and Provider Preferences Around Discussions of Cost of Breast Cancer Care), which is not on this map. Cited by 46 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Understanding and Addressing Patient and Provider Preferences Around Discussions of Cost of Breast Cancer Care
Who cites it
46 citing papers in PubMed, 76 citations in OpenAlex.
- Assessment of Financial Toxicity Among Older Adults With Advanced Cancer.JAMA network open · 2020Trial
- Improving Cancer Patients' Insurance Choices (I Can PIC): A Randomized Trial of a Personalized Health Insurance Decision Aid.The oncologist · 2020Trial
- Communication of Cost in Thyroidectomy: A Mixed-Methods Analysis of Financial Toxicity.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2026Article
- Financial toxicity in patients with newly diagnosed hepatocellular carcinoma: a cross-sectional study.Journal of gastrointestinal oncology · 2025Article
- Insights into Cancer Patients' Experiences and Needs in the Northeast Region of India: A Qualitative Study.Healthcare (Basel, Switzerland) · 2025Article
- Article
- Patient-Provider Cost-of-Care Conversations to Prevent Financial Toxicity.Clinical journal of oncology nursing · 2025Article
- Costs of non-metastatic prostate cancer treatment among privately insured men in the United States.PloS one · 2025Article
- Examining the Relationship Between the Quality of Cost Conversations and Patient Satisfaction in the Oral Health Setting.Journal of patient experience · 2025Article
- Financial Toxicity in Radiation Oncology: Impact for Our Patients and for Practicing Radiation Oncologists.Advances in radiation oncology · 2024Review
- Healthcare price transparency in North America and Europe.The British journal of radiology · 2023Review
- Financial navigation: Staff perspectives on patients' financial burden of cancer care.Journal of cancer survivorship : research and practice · 2023Article
- Financial burden of men with localized prostate cancer: a process paper.Frontiers in psychology · 2023Article
- The DISCO App: A pilot test of a multi-level intervention to reduce the financial burden of cancer through improved cost communication.PEC innovation · 2022Article
- Cancer-Related Care Costs and Employment Disruption: Recommendations to Reduce Patient Economic Burden as Part of Cancer Care Delivery.Journal of the National Cancer Institute. Monographs · 2022Article
- How Do You DISCO? Leveraging the Discussions of Cost App to Reduce Financial Toxicity and Improve Treatment Cost Communication.Oncology issues · 2022Article
- Out-of-Pocket Spending for Thumb Carpometacarpal Arthritis: Capitation Matters.Hand (New York, N.Y.) · 2021Article
- Parent Preferences for Transparency of Their Child's Hospitalization Costs.JAMA network open · 2021Article
- Financial worry and psychological distress among cancer survivors in the United States, 2013-2018.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021Article
- Out-of-Pocket Spending for Cancer Medication, Financial Burden, and Cost Communication with Oncologists in the Last Six Months of Life in Israel.Healthcare (Basel, Switzerland) · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
Abstract
purposeAs one solution to reducing costs and medical bankruptcies, experts have suggested that patients and physicians should discuss the cost of care up front. Whether these discussions are possible in an oncology setting and what their effects on the doctor-patient relationship are is not known.
methodsWe used the National Comprehensive Cancer Network (NCCN) Guidelines and the eviti Advisor platform to show patients with metastatic breast, lung, or colorectal cancer the costs associated with their chemotherapy and/or targeted therapy options during an oncology consultation. We measured provider attitudes and assessed patient satisfaction when consultations included discussion of costs.
resultsWe approached 107 patients; 96 (90%) enrolled onto the study, three (3%) asked if they could be interviewed at a later date, and eight (7%) did not want to participate. Only five of 18 oncologists (28%) felt comfortable discussing costs, and only one of 18 (6%) regularly asked patients about financial difficulties. The majority of patients (80%) wanted cost information, and 84% reported that these conversations would be even more important if their co-pays were to increase. In total, 72% of patients responded that no health care professional has ever discussed costs with them. The majority of patients (80%) had no negative feelings about hearing cost information.
conclusionIn an era of rising co-pays, patients with cancer want cost-of-treatment discussions, and these conversations do not lead to negative feelings in the majority of patients. Additional training to prepare clinicians for how to discuss costs with their patients is needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.